pharmaphorum
JUNE 7, 2024
Discover how compounding pharmacies use genetic information to create precision medications tailored to individual allergies. Learn how personalised treatments can benefit you.
Bio Pharma Dive
JUNE 7, 2024
A vote against MDMA-assisted therapy set back a high-profile treatment. Proponents argue the panel offered few solutions to longstanding problems, making the path forward unclear.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
JUNE 7, 2024
Phase 2 trial reveals significant improvement in MASH patients
Bio Pharma Dive
JUNE 7, 2024
After 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed disappointing obesity drug data and AbbVie got some good trial news.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Pharmaceutical Technology
JUNE 7, 2024
The US Food and Drug Administration (FDA) has criticised the state of Chinese pharma company Jiangsu Hengrui’s facilities in a newly released 483 form.
Pharma Times
JUNE 7, 2024
Early-stage endometriosis now visible through non-invasive imaging
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JUNE 7, 2024
The FDA is looking to ask questions about a change of primary endpoint, treatment cessation and mortality reporting from the donanemab trial.
pharmaphorum
JUNE 7, 2024
Explore how commercialisation is the new frontier for digital innovation in the pharmaceutical industry, with a focus on GLP-1 drugs, digital strategies, and reducing patient acquisition costs.
Pharmaceutical Technology
JUNE 7, 2024
The prognostic factor(s) driving outcomes at the initial stages of hepatocellular carcinoma remain unclear, complicating the treatment choice.
pharmaphorum
JUNE 7, 2024
Nestle Health Science bids to take control of Seres Therapeutics’ oral microbiome product Vowst for preventing C. diff infections.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
JUNE 7, 2024
Agomab Therapeutics has now secured a US Food and Drug Administration (FDA) orphan drug designation for IPF treatment AGMB-447.
pharmaphorum
JUNE 7, 2024
UK group Cycle Pharma has made an unsolicited takeover bid to buy Vanda Pharma, which is already fending off an overture from Future Pak.
Pharmaceutical Technology
JUNE 7, 2024
The facility is expected to allow Orano Med to produce 5,000 doses of lead-212 based radioligand therapies by 2025.
pharmaphorum
JUNE 7, 2024
Learn how building resilience can positively impact cancer trials in the field of oncology. Learn more about CancerEngage.
Pharmaceutical Technology
JUNE 7, 2024
The company will be filing an IND for nicotinamide riboside chloride (NRC), which has received both orphan and rare pediatric designations.
BioSpace
JUNE 7, 2024
Both Eli Lilly and the partnered companies Boehringer Ingelheim and Zealand Pharma have mid-stage data readouts this week, fueling the race in metabolic dysfunction-associated steatohepatitis.
Pharmaceutical Technology
JUNE 7, 2024
Discover Curevac NV's groundbreaking patent for an mRNA-based RSV vaccine, targeting prophylaxis and treatment. Learn about the innovative pharmaceutical composition and method for stimulating a robust immune response against RSV.
BioSpace
JUNE 7, 2024
AbbVie’s antibody-drug conjugate Elahere, developed by ImmunoGen, elicited a nearly 52% objective response rate in heavily pretreated patients with folate receptor-alpha-positive, platinum-sensitive ovarian cancer.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
JUNE 7, 2024
Discover Botanix Pharmaceuticals' patented treatment regime using cannabidiol for dermatitis and skin conditions. Administering between 50-3000 mg daily, this topical solution offers a unique approach to skincare.
pharmaphorum
JUNE 7, 2024
More than 30 years after it was first founded, Geron has claimed FDA approval for its first product – myelodysplastic syndromes (MDS) treatment Rytelo. The US regulator has cleared Rytelo (imetelstat) for adults with lower-risk MDS who have transfusion-dependent anaemia and have stopped responding to or cannot be treated with erythropoiesis-stimulating agents (ESAs) like erythropoietin (EPO).
Pharmaceutical Technology
JUNE 7, 2024
Discover the groundbreaking patent by Syndax Pharmaceuticals Inc for compounds targeting menin-MLL interaction in leukemia treatment. Learn more about this innovative approach to fighting cancer.
BioSpace
JUNE 7, 2024
After rejecting a previous takeover offer from Future Pak, Vanda Pharmaceuticals is now fielding another acquisition proposal from Cycle Pharmaceuticals, which values the biotech at $8 per share.
Pharmaceutical Technology
JUNE 7, 2024
Discover Heidelberg Pharma AG's groundbreaking patent for synthesizing amanitin derivatives to treat breast, pancreatic, and colorectal cancer. Learn more about this innovative method now!
pharmaphorum
JUNE 7, 2024
Join us for an exclusive interview with Dr Suzanne Trudel at ASCO 2024, where she will share insights on the latest advancements in cancer research and treatment. Stay tuned for this exciting conversation!
Pharmaceutical Technology
JUNE 7, 2024
Discover the groundbreaking patent by CSPC Pharmaceutical Group Ltd for a pharmaceutical composition targeting Cx43 hemichannels to treat inflammatory and neurodegenerative diseases like spinal cord injury. Explore the specific antibodies and stabilizing agents within a defined pH range.
BioSpace
JUNE 7, 2024
The companies announced Friday that their candidate survodutide, which is licensed to Boehringer Ingelheim from Zealand Pharma, improved fibrosis in more than 50% of treated patients with metabolic dysfunction-associated steatohepatitis.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
JUNE 7, 2024
Discover the innovative patent by Amneal Pharmaceuticals for a floating gastroretentive composition delivering sustained release of liothyronine. Revolutionizing hypothyroidism treatment with unique design and effective drug delivery.
Fierce Pharma
JUNE 7, 2024
After fessing up to wire fraud charges, a former Takeda employee will be preparing for a sentencing hearing rather than walking down the aisle with $2.3 million garnered through a scheme to defraud | Priya Bhambi, 40, pled guilty to wire fraud charges after running a detailed scheme to scam Takeda into paying for non-existent services from a fake consulting firm.
Pharmaceutical Technology
JUNE 7, 2024
Discover how Allscripts Healthcare Solutions Inc's patented technologies optimize patient overviews in a user-friendly interface. Enhance workflow efficiency with customizable patient data displays.
BioSpace
JUNE 7, 2024
In advance of an advisory committee meeting on Monday, the FDA’s internal reviewers have raised issues regarding Eli Lilly’s Alzheimer’s disease candidate donanemab, flagging problems with its study design and safety outcomes.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
69 
Let's personalize your content